QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

KIDS

QT72OrthoPediatrics Corp.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
18.87
+0.70+3.85%
OverviewShort InterestFilings
KIDSQT72OrthoPediatrics Corp.·NASDAQ
OverviewShort InterestFilings
18.87+3.85%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-1.68
Insider Own-
Shs Outstand25.68M
Perf Week5.83%
Market Cap466.70MForward P/E-EPS next Y-0.81Insider Trans-0.23%Shs Float-Perf Month3.51%
Enterprise Value558.73MPEG-EPS next Q-0.31Inst Own-Short Float-Perf Quarter14.09%
Income-43029413.00P/S1.92EPS this Y29.50%Inst Trans-Short Ratio-Perf Half Y5.36%
Sales243.30MP/B1.27EPS next Y31.80%ROA-7.90%Short Interest-Perf YTD6.25%
Book/sh13.20P/C-EPS next 5Y-ROE-11.42%52W High23.70 -20.38%Perf Year-7.36%
Cash/sh1.99P/FCF-EPS past 3/5Y-ROIC-6.41%52W Low14.42 30.86%Perf 3Y-
Dividend Est.-EV/EBITDA-84.32Sales past 3/5Y24.60% 27.15%Gross Margin73.07%Volatility2.87% 2.87%Perf 5Y-
Dividend TTM-EV/Sales2.30EPS Y/Y TTM37.20%Oper. Margin-12.07%ATR (14)0.78Perf 10Y-
Dividend Ex-Date-Quick Ratio2.37Sales Y/Y TTM18.54%Profit Margin-16.31%RSI (14)61.23Recom2.00
Dividend Gr. 3/5Y-Current Ratio5.21EPS Q/Q-7.69%SMA205.25%Beta1.15Target Price21.00
Payout0.00%Debt/Eq0.31Sales Q/Q13.46%SMA509.34%Rel Volume0.85Prev Close18.17
Employees562LT Debt/Eq0.29EarningsAug 04SMA2007.20%Avg Volume159.94KPrice18.87
IPO DateOct 13, 2017Option/ShortYes / YesEPS/Sales Surpr.-10.53% 1.72%Net Debt/EBITDA-13.89Volume136,433Change3.85%
Analyst Ratings
DateActionAnalystRatingTarget
May-01-26ReiteratedTruist Financial$20 → $17
Apr-24-26ReiteratedCanaccord Genuity$24 → $25
Dec-10-25ReiteratedCanaccord Genuity$24
Oct-29-25ReiteratedNeedhamBuy$42 → $26
Oct-10-25ReiteratedTruist Financial$22 → $18
Oct-10-25ReiteratedStifel NicolausBuy$32 → $20
Oct-10-25ReiteratedPiper SandlerOverweight$44 → $22
Oct-10-25ReiteratedJMP SecuritiesMarket Outperform$35 → $25
Oct-10-25ReiteratedBTIGBuy$44 → $23
Oct-10-25ReiteratedLake StreetBuy$34
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue243236205
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A656456
Gross Profit177173149
Selling, General and Administrative Excl. Other195193167
Research and Development8911
Other Operating Expense500
Operating Income-30-29-30
Interest Expense763
Unusual Expense
———
Non-Operating Income (Expense)-2410
Net Income Before Taxes-40-39-42
Income Taxes00-4
Consolidated Net Income-40-40-38
Net Income From Continuing Operations-40-40-38
Net Income-40-40-38
EPS (Recurring)-1.68-1.69-1.64
EPS (Basic, Before Extraordinaries)-1.68-1.69-1.64
EPS (Diluted)-1.68-1.69-1.64
EBITDA-7-12-20
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.861.73—
Gross Margin72.8473.3172.68
Operating Margin-12.35-12.29-14.63
Net Margin-16.46-16.95-18.54
Shares Outstanding242323
Market Capitalization453408—
Operating Lease Expense
———
Insider Trading Volume
$20.99$18.95$16.91$14.88$12.84● Close Price0.00M0.25M0.50M0.75M1.00MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Odle Gregory APresident of ScoliosisMar 16 '26Sale17.258,433145,469187,735Mar 17 12:00 AM
Hite FredCOO and CFOMar 16 '26Sale17.2512,993224,129277,477Mar 17 12:00 AM
Gerritzen Daniel JGeneral Counsel and SecretaryMar 16 '26Sale17.258,614148,592149,533Mar 17 12:00 AM
Hauser Joseph WPres. Trauma & Def. CorrectionMar 16 '26Sale17.258,596148,281194,767Mar 17 12:00 AM
Bailey David RPresident and CEOMar 16 '26Sale17.2519,535336,979298,020Mar 17 12:00 AM
Hite FredCOO and CFOAug 21 '25Buy19.415,07698,525213,065Aug 25 12:00 AM
Gerritzen Daniel JGeneral Counsel and SecretaryMar 18 '25Sale24.865,310132,007110,767Mar 18 12:00 AM
Bailey David RPresident and CEOMar 18 '25Sale24.866,620164,573319,155Mar 18 12:00 AM
Hite FredCOO and CFOMar 18 '25Sale24.866,443160,173207,989Mar 18 12:00 AM
Odle Gregory APresident of ScoliosisMar 18 '25Sale24.865,359133,225148,788Mar 18 12:00 AM
Hauser Joseph WPres. Trauma & Def. CorrectionMar 18 '25Sale24.865,300131,758137,663Mar 18 12:00 AM
Gerritzen Daniel JGeneral Counsel and SecretaryAug 21 '24Sale29.3010,000293,00077,304Aug 22 12:00 AM
Bailey David RPresident and CEOMar 11 '24Sale27.593,21388,647139,384Mar 12 12:00 AM
Gerritzen Daniel JGeneral Counsel and SecretaryMar 11 '24Sale27.592,74175,62452,403Mar 12 12:00 AM
Odle Gregory APresident of ScoliosisMar 11 '24Sale27.592,76876,36980,473Mar 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR